Dr. Kachnic belongs to a number of professional organizations including ASTRO, ASCO, AACR, Radiation Research and the International Society of Gastrointestinal Oncology. She serves on the editorial boards of the Journal of the National Cancer Institute and Gastrointestinal Cancer Research, and contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment Editorial Board and to the U.S. Department of Defense Medical Research Study Sections. Her primary areas of interest include colo-rectal and anal malignancies, image-guided radiation delivery, outcomes/symptoms management research and translational research. She is actively involved in the Radiation Therapy Oncology Group’s GI and Outcome strategic committees and has been the RTOG Chairperson of Symptom Management since 2003. She also serves as GI Radiation Oncology Chair and Discipline Vice-chair of the Radiation Oncology Committee for the Southwest Oncology Group. As such, she has been given the opportunity to serve as principal or co-principal investigator on several national trials, including RTOG 0529 - a phase II trial evaluating dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. As a tribute to these efforts, Dr. Kachnic has been awarded funding as Principal Investigator, National Cancer Institute, U10 CA37422, “Community Clinical Oncology Program (CCOP) Radiation Therapy Oncology Group,” and is the 2008 recipient of the first RTOG “Next Generation Investigator” Award.
Dr. Kachnic is Chairperson of the American College of Radiology Written Board in gastrointestinal cancers, Vice-chairperson of the GI committee at the American College of Radiology’s Q-RRO (Quality Research in Radiation Oncology) and serves on the Intergroup’s Colon Cancer Task Force. Dr. Kachnic is the principle investigator on several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects. Her current laboratory work relates to the development of potential targets for molecularly directed therapies by identifying genetic defects in the DNA repair pathway involving the Fanconi Anemia genes. Dr. Kachnic’s research has resulted in numerous peer-reviewed manuscripts, book chapters and reviews.
Ariel Hirsch, MD
Dr. Hirsch has served as a featured community speaker at the Breast Cancer Awareness Survivors Meeting on Life Before and After Cancer and is a faculty member for the breast and prostate cancer patient support groups. She was a featured presenter for the International Association of Medical Science Educators Webcast Audio Seminar Series on Medical Education and the Next Generation of Learners. She is actively involved in promoting clinical and educational research activities at Boston University Medical Center, and was awarded funding as Principal Investigator for an RSNA R&E Foundation Education Seed Grant investigating the integration of radiation oncology into the core undergraduate medical curriculum.
Dr. Hirsch belongs to a number of professional organizations including ASTRO, ASCO, RSNA and ACR. In addition, she serves as Block Director for the Oncology Block in the second-year medical school Disease and Therapy course, is the co-founder of the Early Career Faculty Professional Development in Education Program, is Physician Director of Radiation Oncology Quality Assurance, serves on the Mentoring task force, and serves as Chairperson of the medical school Professionalism Committee. In addition, she serves as Site Coordinator for the Harvard Radiation Oncology Program. Dr. Hirsch has mentored many students who have been extremely successful in producing scholarly and often nationally recognized work.
Dr. Hirsch has received numerous clinical, research and teaching awards including: the AAWR Professional Leadership Award for Early Career Women Faculty, the RSNA Roentgen Resident/Fellow Research Award, the American Medical Association Excellence in Medicine Young Physician Leadership Award, the IAMSE Scholarship, and the William R. Cranley Medical Student Teaching Award. She is a Harvard Macy Scholar, having participated in the Harvard Macy Institute Programs for Comprehensive Assessment in Health Science Education, the program for Educators in the Health Professions and Leading Innovations in Health Care and Education. Dr. Hirsch serves on the Editorial Board of Pain Physician, as a reviewer for the Journal of the American College of Radiology as an ad-hoc reviewer for Breast Cancer Research and Treatment and the International Journal of Radiation Oncology, Biology and Physics, and is an author for the Oncology section of Up-to-Date Online. Her research has resulted in various peer-reviewed manuscripts, chapters and reviews.
Minh-Tam Truong, MD
Dr. Truong belongs to a number of professional organizations including ASTRO and ACR. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. Her primary areas of interest include head and neck, skin, central nervous system malignancies and benign disease including airway amyloidosis. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer, a study known as “Role of CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy”. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects.
Gregory Russo, MD
Dr. Russo is a member of Alpha Omega Alpha, the National Honor Medical Society. He has received a number of grants and scholarships that have provided him with the opportunity to study radiation oncology in other parts of the world, including a one-month exchange to the Osaka City University Hospital in Osaka, Japan. Moreover, Dr. Russo has performed original research in the areas of normal tissue toxicity and molecular markers relevant to treatment outcomes in head and neck cancer. Such work has resulted in Dr. Russo being the recipient of the 2007 RSNA Resident Research Award.
Clinically, Dr. Russo is specializing in treating thoracic and gynecologic malignancies and has strong interests in applying new radiation delivery technologies to make treatments safer and more effective for all patients and in providing resident and medical student education in radiation oncology.